Welcome to the EDIBLE website

Welcome to the EDIBLE research study website. EDIBLE is an interventional clinical trial in 120 children and adolescents with epilepsy due to Focal Cortical Dysplasia (FCD) type II.

The standard treatment for children and adolescents with difficult to treat epilepsy is resective surgery. The EDIBLE study will investigate the role and possible benefits of a ketogenic diet (KD) taken for six months before resective surgery, on seizure outcome and other factors. The KD is a high fat – low carbohydrate diet that must be prescribed by an experienced dietitian. To find out more about the EDIBLE trial please see the Trial Summary section.

EDIBLE is a multi-centre international trial that will take place in several countries across Europe including the United Kingdom, Czech Republic, Germany, Italy, France, Switzerland and Austria and the USA. To find out which centres are taking part in the study please see the Recruiting Centres section.

The current page will be updated to provide details regarding the recruitment progress of the study.


I'm fine with this [X]

The site uses cookies, some may have been set already. Please refer to our privacy policy & cookie usage statement.
If you continue to use the site we'll assume you're happy to accept the cookies.